Publications by authors named "Deepa Rajagopal"

Claim this Profile
I
Immune-related adverse events of antibody-based biological medicines in cancer therapy.
Deepa Rajagopal, Elliot MacLeod, Diana Corogeanu, Sandrine Vessillier

J Cell Mol Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety.
Elliot MacLeod, Deepa Rajagopal, Sandrine Vessillier

J Vis Exp· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous evaluation of treatment efficacy and toxicity for bispecific T-cell engager therapeutics in a humanized mouse model.
Jiwon Yang, Jing Jiao, Kyle M Draheim, Guoxiang Yang, Hongyuan Yang, Deepa Rajagopal

FASEB J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic host susceptibility among multiple species to intranasal SARS-CoV-2 identifies diverse virological, biodistribution and pathological outcomes.
Neil Berry, Deborah Ferguson, Sarah Kempster, Jo Hall, Claire Ham, Deepa Rajagopal

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An accurate and rapid single step protocol for enumeration of cytokine positive T lymphocytes.
Deepa Rajagopal, Linhua Tian, Shiqiu Xiong, Lili Wang, Jonathan Campbell

J Immunol Regen Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody.
Jantipa Jobsri, Alex Allen, Deepa Rajagopal, Michael Shipton, Kostya Kanyuka

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.
Deepa Rajagopal, Carine Paturel, Yannis Morel, Satoshi Uematsu, Shizuo Akira

Blood· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of a novel, orally active PDE4 inhibitor.
Sunanda G Dastidar, Abhijit Ray, Rajkumar Shirumalla, Deepa Rajagopal, Shiwani Chaudhary

Pharmacology· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation.
Deepa Rajagopal, Robert W Maul, Amalendu Ghosh, Tirtha Chakraborty, Ahmed Amine Khamlichi

J Exp Med· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hijacked DNA repair proteins and unchained DNA polymerases.
Huseyin Saribasak, Deepa Rajagopal, Robert W Maul, Patricia J Gearhart

Philos Trans R Soc Lond B Biol Sci· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
Sunanda G Dastidar, Deepa Rajagopal, Abhijit Ray

Curr Opin Investig Drugs· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules.
Deepa Rajagopal, Vineeta Bal, Satyajit Mayor, Anna George, Satyajit Rath

Eur J Immunol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent.
Mona K Tewari, Gomathinayagam Sinnathamby, Deepa Rajagopal, Laurence C Eisenlohr

Nat Immunol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
Aadish Dani, Ashutosh Chaudhry, Paushali Mukherjee, Deepa Rajagopal, Sumeena Bhatia

J Cell Sci· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity & overlap in the mechanisms of processing protein antigens for presentation to T cells.
Deepa Rajagopal, Vineeta Bal, Anna George, Satyajit Rath

Indian J Med Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mimicry of native peptide antigens by the corresponding retro-inverso analogs is dependent on their intrinsic structure and interaction propensities.
Deepak T Nair, Kanwal J Kaur, Kavita Singh, Paushali Mukherjee, Deepa Rajagopal

J Immunol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-gamma bioassay: development of a sensitive method by measuring nitric oxide production by peritoneal exudate cells from C57BL/6 mice.
Shruti Malu, Shrividhya Srinivasan, Prasanta Kumar Maiti, Deepa Rajagopal, Beena John

J Immunol Methods· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of IL-12-independent and IL-12-dependent pathways in regulating generation of the IFN-gamma component of T cell responses to Salmonella typhimurium.
Beena John, Deepa Rajagopal, Achal Pashine, Satyajit Rath, Anna George

J Immunol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis